BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27386591)

  • 1. [A choice of a nonsteroidal anti-inflammatory drug with regard to gastrointestinal and cardiovascular' risks].
    Pakhomova IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(4):85-89. PubMed ID: 27386591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [NSAID GASTROPATHY IN PATIENTS WITH COMORBID DISEASES].
    Morozova TE; Rykova SM; Chukina MA
    Eksp Klin Gastroenterol; 2015; (6):64-70. PubMed ID: 26817107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal.
    Davies NM; Reynolds JK; Undeberg MR; Gates BJ; Ohgami Y; Vega-Villa KR
    Expert Rev Neurother; 2006 Nov; 6(11):1643-55. PubMed ID: 17144779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonsteroidal antiinflammatory drug-related injury to the gastrointestinal tract: clinical picture, pathogenesis, and prevention.
    Scarpignato C; Hunt RH
    Gastroenterol Clin North Am; 2010 Sep; 39(3):433-64. PubMed ID: 20951911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Gastrointestinal and Cardiovascular Risk in Patients with Degenerative Lumbar Spinal Disease.
    Yang JH; Lee BH; Eum KS; Suk KS; Park JO; Kim HS; Lee HM; Moon SH
    Clin Orthop Surg; 2020 Sep; 12(3):343-352. PubMed ID: 32904035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.
    Chan FK; Abraham NS; Scheiman JM; Laine L;
    Am J Gastroenterol; 2008 Nov; 103(11):2908-18. PubMed ID: 18853980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus about managing gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs?
    Yeomans ND
    BMC Med; 2015 Mar; 13():56. PubMed ID: 25858463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NSAID-induced Gastrointestinal Injury: A Focused Update for Clinicians.
    Scheiman JM
    J Clin Gastroenterol; 2016 Jan; 50(1):5-10. PubMed ID: 26524151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and gastrointestinal effects of COX-2 inhibitors and NSAIDs: achieving a balance.
    Borer JS; Simon LS
    Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S14-22. PubMed ID: 16168077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drugs in the treatment of pericarditis.
    Schifferdecker B; Spodick DH
    Cardiol Rev; 2003; 11(4):211-7. PubMed ID: 12852799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Balancing cardiovascular and gastrointestinal risks in patients with osteoarthritis receiving nonsteroidal anti‑inflammatory drugs. A summary of guidelines from an international expert group.
    Mosleh W; Farkouh ME
    Pol Arch Med Wewn; 2016; 126(1-2):68-75. PubMed ID: 26810416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Nonsteroidal antiinflammatory drugs: gastrointestinal and cardiovascular and renal safety].
    Oscanoa-Espinoza T; Lizaraso-Soto F
    Rev Gastroenterol Peru; 2015 Jan; 35(1):63-71. PubMed ID: 25875519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balancing the gastrointestinal benefits and risks of nonselective NSAIDs.
    Peura DA; Goldkind L
    Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S7-13. PubMed ID: 16168079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs].
    van den Bemt BJ; Benraad HB; Rasker JJ
    Ned Tijdschr Geneeskd; 2007 May; 151(19):1062-7. PubMed ID: 17552414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practical approaches to minimizing gastrointestinal and cardiovascular safety concerns with COX-2 inhibitors and NSAIDs.
    Scheiman JM; Fendrick AM
    Arthritis Res Ther; 2005; 7 Suppl 4(Suppl 4):S23-9. PubMed ID: 16168078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to optimize treatment with NSAIDs in patients at risk for gastrointestinal and cardiovascular adverse events.
    Scheiman JM; Hindley CE
    Clin Ther; 2010 Apr; 32(4):667-77. PubMed ID: 20435236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of nonsteroidal anti-inflammatory agents on the gastrointestinal tract].
    Bures J; Rejchrt S; Kopácová M; Siroký M
    Cas Lek Cesk; 2002 Oct; 141(21):673-9. PubMed ID: 12564374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NSAID dilemma: managing osteoarthritis in high-risk patients.
    Roth SH; Anderson S
    Phys Sportsmed; 2011 Sep; 39(3):62-74. PubMed ID: 22030942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using NSAIDs in cardiovascular disease.
    Drug Ther Bull; 2010 Mar; 48(3):26-9. PubMed ID: 20200145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks.
    Chan FK
    Nat Clin Pract Gastroenterol Hepatol; 2006 Oct; 3(10):563-73. PubMed ID: 17008926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.